Optimizing CRISPR/Cas9 Editing of Repetitive Single Nucleotide Variants

被引:3
|
作者
Usher, Inga [1 ]
Ligammari, Lorena [1 ]
Ahrabi, Sara [2 ]
Hepburn, Emily [3 ]
Connolly, Calum [3 ]
Bond, Gareth L. [4 ]
Flanagan, Adrienne M. [1 ,5 ]
Cottone, Lucia [1 ]
机构
[1] UCL, UCL Canc Inst, Dept Pathol Res, London, England
[2] UCL, UCL Canc Inst, Dept Haematol, London, England
[3] UCL, UCL Med Sch, London, England
[4] Univ Birmingham, Inst Canc & Genom Sci, Birmingham, England
[5] Royal Natl Orthopaed Hosp, Dept Histopathol, London, England
来源
关键词
CRISPR; Cas9; genome editing; prime editing; homology directed repair (HDR); cell line; stem cells; CELLS; PRECISE; NUCLEASE;
D O I
10.3389/fgeed.2022.932434
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
CRISPR/Cas9, base editors and prime editors comprise the contemporary genome editing toolbox. Many studies have optimized the use of CRISPR/Cas9, as the original CRISPR genome editing system, in substituting single nucleotides by homology directed repair (HDR), although this remains challenging. Studies describing modifications that improve editing efficiency fall short of isolating clonal cell lines or have not been validated for challenging loci or cell models. We present data from 95 transfections using a colony forming and an immortalized cell line comparing the effect on editing efficiency of donor template modifications, concentration of components, HDR enhancing agents and cold shock. We found that in silico predictions of guide RNA efficiency correlated poorly withactivity in cells. Using NGS and ddPCR we detected editing efficiencies of 5-12% in the transfected populations which fell to 1% on clonal cell line isolation. Our data demonstrate the variability of CRISPR efficiency by cell model, target locus and other factors. Successful genome editing requires a comparison of systems and modifications to develop the optimal protocol for the cell model and locus. We describe the steps in this process in a flowchart for those embarking on genome editing using any system and incorporate validated HDR-boosting modifications for those using CRISPR/Cas9.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Genomic editing in Burkholderia multivorans by CRISPR/Cas9
    Ferreira, Mirela R.
    Queiroga, Vasco
    Moreira, Leonilde M.
    APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2024, 90 (02)
  • [32] Advances in therapeutic CRISPR/Cas9 genome editing
    Savic, Natasa
    Schwank, Gerald
    TRANSLATIONAL RESEARCH, 2016, 168 : 15 - 21
  • [33] A glance at genome editing with CRISPR–Cas9 technology
    Antara Barman
    Bornali Deb
    Supriyo Chakraborty
    Current Genetics, 2020, 66 : 447 - 462
  • [34] Translating CRISPR/Cas9 genome editing into therapeutics
    Barnes, T. M.
    HUMAN GENE THERAPY, 2016, 27 (11) : A140 - A141
  • [35] Editing streptomycete genomes in the CRISPR/Cas9 age
    Alberti, Fabrizio
    Corre, Christophe
    NATURAL PRODUCT REPORTS, 2019, 36 (09) : 1237 - 1248
  • [36] Efficient Mitochondrial Genome Editing by CRISPR/Cas9
    Jo, Areum
    Ham, Sangwoo
    Lee, Gum Hwa
    Lee, Yun-Il
    Kim, SangSeong
    Lee, Yun-Song
    Shin, Joo-Ho
    Lee, Yunjong
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [37] CRISPR/Cas9: Transcending the Reality of Genome Editing
    Chira, Sergiu
    Gulei, Diana
    Hajitou, Amin
    Zimta, Alina-Andreea
    Cordelier, Pierre
    Berindan-Neagoe, Ioana
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2017, 7 : 211 - 222
  • [38] CRISPR/Cas9 editing of carotenoid genes in tomato
    D'Ambrosio, Caterina
    Stigliani, Adriana Lucia
    Giorio, Giovanni
    TRANSGENIC RESEARCH, 2018, 27 (04) : 367 - 378
  • [39] Genome editing with AAV using CRISPR/Cas9
    Wilson, J. M.
    HUMAN GENE THERAPY, 2016, 27 (11) : A18 - A18
  • [40] GENE EDITING IN CHONDROCYTES USING CRISPR/CAS9
    Gibson, G.
    Yang, M.
    OSTEOARTHRITIS AND CARTILAGE, 2016, 24 : S2 - S3